To verify the value of liver tumor markers, HALP score, PLR, and NLR on the prognosis of ICC patients, we analyzed the relationship between recurrent sites and the clinicopathological parameters, and the results of univariate analysis are summarized in Table 4. This evidence concerns the gene NAT10 and intrahepatic cholangiocarcinoma.